Unità di Oculistica, IRCCS Ospedale San Raffaele

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD	Geographic Atrophy, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 2	2026-10-05		NCT06659549

Clinical trials